[
    [
        {
            "time": "2021-12-05",
            "original_text": "疫苗巨头为何想“杀掉快下蛋的鸡”？董事长回应，71亿隐秘野心曝光",
            "features": {
                "keywords": [
                    "沃森生物",
                    "疫苗",
                    "股权转让",
                    "李云春",
                    "高瓴资本",
                    "泰格系"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "疫苗巨头为何想“杀掉快下蛋的鸡”？董事长回应，71亿隐秘野心曝光",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-12-06",
            "original_text": "沃森生物“神操作” 高瓴资本和“泰格系”两度接盘",
            "features": {
                "keywords": [
                    "沃森生物",
                    "高瓴资本",
                    "泰格系",
                    "股权转让"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物“神操作” 高瓴资本和“泰格系”两度接盘",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-12-07",
            "original_text": "沃森生物董事长李云春回应股权转让：调整战略发力新冠疫苗 资产异常",
            "features": {
                "keywords": [
                    "沃森生物",
                    "李云春",
                    "新冠疫苗",
                    "战略调整"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物董事长李云春回应股权转让：调整战略发力新冠疫苗 资产异常",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-12-08",
            "original_text": "“圈内人”盯上沃森疫苗项目，泰格医药投资版图浮现",
            "features": {
                "keywords": [
                    "沃森生物",
                    "泰格医药",
                    "疫苗项目",
                    "投资版图"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "“圈内人”盯上沃森疫苗项目，泰格医药投资版图浮现",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-12-09",
            "original_text": "沃森生物按下子公司股权转让暂停键 新战略将布局新冠疫苗 资产异常",
            "features": {
                "keywords": [
                    "沃森生物",
                    "子公司",
                    "股权转让",
                    "新冠疫苗"
                ],
                "sentiment_score": 0.1,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物按下子公司股权转让暂停键 新战略将布局新冠疫苗 资产异常",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-12-10",
            "original_text": "21深度｜沃森生物“贱卖”子公司疑团背后：或为实现股权激励考核 多次“倒买倒卖”错失好资产 资产异常",
            "features": {
                "keywords": [
                    "沃森生物",
                    "贱卖",
                    "子公司",
                    "股权激励",
                    "资产异常"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "21深度｜沃森生物“贱卖”子公司疑团背后：或为实现股权激励考核 多次“倒买倒卖”错失好资产 资产异常",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-12-11",
            "original_text": "沃森生物71亿隐秘野心：高瓴资本、“泰格系”两度接盘，李云春为何弃泽润如鸡肋？",
            "features": {
                "keywords": [
                    "沃森生物",
                    "高瓴资本",
                    "泰格系",
                    "李云春",
                    "隐秘野心"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物71亿隐秘野心：高瓴资本、“泰格系”两度接盘，李云春为何弃泽润如鸡肋？",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]